Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedDec 11, 2013Aminophylline 250mg 10mlThe firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml...Main Street Family Pharmacy, LLC · D-039-2014Class IITerminatedDec 11, 2013Amikacin 500mg 2mlThe firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml...Main Street Family Pharmacy, LLC · D-038-2014Class IITerminatedDec 11, 2013Amikacin 250mg/ml 2ml vialThe firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml...Main Street Family Pharmacy, LLC · D-037-2014Class IITerminatedDec 11, 2013Amikacin 250mg/ml 2mlThe firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml...Main Street Family Pharmacy, LLC · D-036-2014Class IITerminatedDec 11, 2013AMIC-12 w/out lido10mlThe firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml...Main Street Family Pharmacy, LLC · D-035-2014Class IITerminatedDec 11, 2013AMIC-12 with lido 10mlThe firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml...Main Street Family Pharmacy, LLC · D-034-2014Class IITerminatedDec 11, 2013Alprostadil 40mgThe firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml...Main Street Family Pharmacy, LLC · D-033-2014Class IITerminatedDec 11, 2013Alprostadil 20mcg/ml 25mlThe firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml...Main Street Family Pharmacy, LLC · D-032-2014Class IITerminatedDec 11, 2013Alprostadil 100mcg/ml 10mlThe firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml...Main Street Family Pharmacy, LLC · D-031-2014Class IITerminatedDec 11, 2013AlphahydroxyprogesteroneThe firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml...Main Street Family Pharmacy, LLC · D-030-2014Class IITerminatedDec 11, 2013Adenosine MonophosphateThe firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml...Main Street Family Pharmacy, LLC · D-029-2014Class IITerminatedDec 11, 2013Adenosine 35 mg/mlThe firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml...Main Street Family Pharmacy, LLC · D-028-2014Class IITerminatedDec 11, 2013Acetylcystein 20% 90mlThe firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml...Main Street Family Pharmacy, LLC · D-027-2014Class IITerminatedDec 11, 2013Acetylcystein 10% 100mg/ml 4mlThe firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml...Main Street Family Pharmacy, LLC · D-026-2014Class IITerminatedDec 11, 2013Acetylcystein 10% 120mlThe firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml...Main Street Family Pharmacy, LLC · D-025-2014Class IITerminatedDec 11, 201317-P 1mlThe firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml...Main Street Family Pharmacy, LLC · D-024-2014Class IITerminatedDec 11, 2013Morphine Sulfate InjectionLack of Assurance of Sterility: Confirmed customer report of leakage of vial contents due to the breaking of the vial neck.Hospira, Inc. · D-023-2014Class IIITerminatedDec 4, 2013LoratadineFailed Tablet/Capsule Specifications: The products are being recalled due to chipped and broken tablets.Novartis Consumer Health · D-022-2014Class ITerminatedDec 4, 2013J.R. Jack Rabbit All Natural Herbal SupplementMarketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that J.R. Jack Rabbit Male Enhancement product was found to contain two...Jack Rabbit, Inc · D-021-2014Class IIITerminatedDec 4, 2013Acanya (Clindamycin Phosphate and Benzoyl Peroxide) Gel 1.2% and 2.5%Labeling: Incorrect or Missing Lot and/or Exp Date: This recall is being carried out due to an incorrect expiration date assigned to a lot of physicians samples.Valeant Pharmaceuticals North Am · D-020-2014Class IITerminatedDec 4, 2013Cetacaine Liquid Topical AnestheticSubpotent Drug: Cetacaine Topical Anesthetic Liquid is being recalled because one of the three active ingredients, tetracaine, is below the specification limit at the 21...Cetylite Industries, Inc. · D-019-2014Class IITerminatedDec 4, 2013Alprazolam Orally Disintegrating TabletsFailed Tablet/Capsule Specifications; partial tablet erosion resulting in tablet weights below specification in some tabletsActavis Elizabeth LLC · D-018-2014Class IITerminatedDec 4, 2013Acyclovir Tablets USP 800 mgPresence of Particulate Matter: Product from lot KF2199, may contain tablets with pieces of nitrile rubber glove embedded within the tablets.Apotex Inc. · D-017-2014Class IIITerminatedDec 4, 2013PACLITAXEL INJECTIONLabeling: Incorrect or Missing Package Insert- Missing text on the product insert in the "Clinical Studies" and "Specific Adverse Events" sections.Fresenius Kabi USA, LLC · D-016-2014Class ITerminatedNov 27, 2013Affirm XL Nutritional SupplementMarketed Without An Approved NDA/ANDA: FDA analysis found the product to contain sulfoaildenafil, an analogue of sildenafil which is an ingredient in an FDA-approved...Affirm XL, Inc. · D-015-2014Class IITerminatedNov 27, 2013AldactoneMarketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing...Pfizer Us Pharmaceutical Group · D-014-2014Class IITerminatedNov 27, 2013Ondansetron InjectionPresence of Particular Matter: Potential vendor glass issue - glass spiticules (glass strands) were identified during site inspection of the vials.Hospira Inc. · D-013-2014Class IITerminatedNov 27, 2013Metoclopramide InjectionPresence of Particulate Matter: Potential vendor glass issue - glass spiticules (glass strands) were identified during site inspection of the vials.Hospira Inc. · D-012-2014Class IITerminatedNov 27, 2013Spironolactone tabletsMarketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing...Greenstone Llc · D-011-2014Class IITerminatedNov 27, 2013Spironolactone tabletsMarketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing...Greenstone Llc · D-010-2014Class IITerminatedNov 27, 2013Omeprazole Delayed-Release CapsulesFailed Tablet/Capsule Specification: some capsules over time do not meet or are suspected to not meet the specification for acid resistance.Kremers Urban Pharmaceuticals, Inc. · D-009-2014Class IIITerminatedNov 27, 2013Derma-Smoothe/FSSubpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-008-2014Class IIITerminatedNov 27, 2013Derma-Smoothe/FSSubpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.Hill Dermaceuticals, Inc. · D-007-2014Class IITerminatedNov 27, 2013Acetaminophen suspension liquidDefective Delivery System: There is a remote potential that cartons of product could be co-packaged with an oral dosing syringe without dose markings.L. Perrigo Co. · D-006-2014Class IITerminatedNov 27, 2013Acetaminophen suspension liquidDefective Delivery System: There is a remote potential that cartons of product could be co-packaged with an oral dosing syringe without dose markings.L. Perrigo Co. · D-005-2014Class IITerminatedNov 27, 2013Acetaminophen suspension liquidDefective Delivery System: There is a remote potential that cartons of product could be co-packaged with an oral dosing syringe without dose markings.L. Perrigo Co. · D-004-2014Class IITerminatedNov 27, 2013Acetaminophen suspension liquidDefective Delivery System: There is a remote potential that cartons of product could be co-packaged with an oral dosing syringe without dose markings.L. Perrigo Co. · D-003-2014Class IITerminatedNov 27, 2013Oxcarbazepine Oral SuspensionResuspension Problems: Recalled lot did not meet resuspendability requirements.Boehringer Ingelheim Roxane Inc · D-002-2014Class IITerminatedNov 27, 2013CopaxonePresence of Particulate Matter: A foreign particle found in a pre-filled syringe was reported through a consumer complaint about a pre-filled syringe.Teva Pharmaceuticals USA · D-001-2014Class IITerminatedNov 13, 2013Propofol Injectable EmulsionPresence of Particulate Matter: Visible particles embedded in the glass identified during a retain sample inspection.Hospira Inc. · D-66637-001